Literature DB >> 7947239

Glucose 6-phosphate dehydrogenase deficiency and red cell membrane defects: additive or synergistic interaction in producing chronic haemolytic anaemia.

F Alfinito1, V Calabro, M D Cappellini, G Fiorelli, S Filosa, A Iolascon, E Miraglia del Giudice, S Perrotta, R Migliorati, D Vallone.   

Abstract

We have investigated two unrelated patients with congenital haemolytic anaemia in both of whom we found a combination of hereditary spherocytosis (HS) and glucose-6-phosphate dehydrogenase (G6PD) deficiency. Segregation of the two defects was documented in both families, who had different molecular abnormalities for both HS and G6PD deficiency. In one family the propositus had a reduced level of spectrin and G6PD Seattle (282Asp-->His). In the other family the propositus had a band 3 abnormality and was heterozygous for G6PD Mediterranean (188Ser-->Phe). From a comparison of clinical and haematological findings in family members with either or both abnormalities we conclude that in one case the two defects exhibited a synergistic effect, resulting in a severe chronic haemolytic anaemia; whereas in the other the association was simply additive.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7947239     DOI: 10.1111/j.1365-2141.1994.tb04885.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  2 in total

1.  Molecular Characterization of G6PD Deficiency: Report of Three Novel G6PD Variants.

Authors:  Arun Kumar Arunachalam; S Sumithra; Madhavi Maddali; N A Fouzia; Aby Abraham; Biju George; Eunice S Edison
Journal:  Indian J Hematol Blood Transfus       Date:  2019-10-16       Impact factor: 0.900

2.  Concomitant Hereditary Spherocytosis and Pyruvate Kinase Deficiency in a Spanish Family with Chronic Hemolytic Anemia: Contribution of Laser Ektacytometry to Clinical Diagnosis.

Authors:  Joan-Lluis Vives Corrons; Elena Krishnevskaya; Laura Montllor; Valentina Leguizamon; Marta Garcia Bernal
Journal:  Cells       Date:  2022-03-28       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.